Advances in the biology of malignant pleural mesothelioma

P. A. Zucali, G. L. Ceresoli, F. De Vincenzo, M. Simonelli, E. Lorenzi, L. Gianoncelli, A. Santoro

Research output: Contribution to journalArticle

Abstract

Malignant pleural mesothelioma is a highly aggressive cancer with a very poor prognosis. Although the mechanism of carcinogenesis is not fully understood, approximately 80% of malignant pleural mesothelioma can be attributed to asbestos fiber exposure. This disease is largely unresponsive to conventional chemotherapy or radiotherapy, and most patients die within 10-17. months of their first symptoms. Currently, malignant pleural mesothelioma therapy is guided by clinical stage and patient characteristics rather than by the histological or molecular features of the tumor. Several molecular pathways involved in malignant pleural mesothelioma have been identified; these include cell cycle regulation, apoptosis, growth factor pathways, and angiogenesis. Unfortunately, several agents targeting these processes, including erlotinib, gefitinib, and imatinib, have proven ineffective in clinical trials. A greater understanding of the molecular pathways involved in malignant pleural mesothelioma is needed to develop better diagnostics, therapeutics, and preventative measures. Moreover, understanding the biological basis of mesothelioma progression may facilitate personalized treatment approaches, and early identification of poor prognostic indicators may help reduce the heterogeneity of the clinical response. This paper reviews advances in the molecular biology of malignant pleural mesothelioma in terms of pathogenesis, the major molecular pathways and the associated therapeutic strategies, and the roles of biomarkers.

Original languageEnglish
Pages (from-to)543-558
Number of pages16
JournalCancer Treatment Reviews
Volume37
Issue number7
DOIs
Publication statusPublished - Nov 2011

Keywords

  • Malignant mesothelioma
  • Molecular pathways
  • Targeted therapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Advances in the biology of malignant pleural mesothelioma'. Together they form a unique fingerprint.

  • Cite this